Acknowledgment
- PDF / 116,360 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 74 Downloads / 166 Views
ACKNOWLEDGMENT
Ă“ Springer International Publishing Switzerland 2012
Dear Reader, As we reach the final issue of Molecular Diagnosis & Therapy for 2012, we hope you have found the articles published throughout the year to be interesting and informative. The editors and publishing staff have appreciated the high quality of content contributed to the journal this year and look forward to keeping you up to date with topical issues in the fields of diagnostics and personalized medicine in 2013. Following the acquisition of the Adis journals at the end of last year by Springer Science+Business Media, we have been working to transition the production and fulfillment of the Adis journals into Springer processes. This integration will be complete by the end of 2012, such that production and delivery of all Adis journals will be fully transitioned for the first issues of 2013. Adis journal content will be available on a new and improved online platform. We aim to transfer seamlessly all existing subscribers so their access is unaffected, and we will be in regular communication with subscribers as we go through this transition. We are pleased that Springer has decided to keep the Adis brand and recognizes the core values that the brand represents. We are confident that the association with Springer will lead to increased awareness and usage of Adis content, further driving impact factors and recognition. Collectively, we feel that the future for Adis looks bright, and we are happy with the acquisition by Springer. The high quality of Adis Journals was acknowledged in the new ISI impact factors for 2011, with the majority of our titles making gains over 2010. The most impressive gains were made by Clinical Pharmacokinetics (5.398), with a 19.6% increase, Drugs (4.226), which increased by 13%, and Clinical Drug Investigation (1.822), an increase of 12.3% over 2010. Two of our journals received their first impact factors for 2011—Pediatric Drugs, with an impact factor of 1.786, and The Patient (0.571). We would like to say a big thank you to all of the authors who have contributed articles to Molecular Diagnosis & Therapy within the last 12 months. Without their hard work and diligence, we would not have been able to publish the journal. The quality of published articles also reflects the significant time and effort dedicated by the peer reviewers, who ensure that we continue to publish content of the highest possible standard. In addition to the members of our Honorary Editorial Board, we would like to thank the following individuals, who acted as referees for articles in Molecular Diagnosis & Therapy in 2012: Omar Abdel-Wahab, USA Nishant Agrawal, USA Alexandru Almasan, USA Mei-Kim Ang, Singapore Tiziano Barbui, Italy Michael A. Bookman, USA Susan Branford, Australia John Carlquist, USA Roy F. Chemaly, USA Louis Chesler, UK Timothy Chevassut, UK Frederic Chibon, France Jean-Claude Chomel, France Eliecer Coto, Spain Francis Couturaud, France Marc de Hert, Belgium Angela DeMichele, USA Roland Diel, Germany David W. Dowdy, USA Zo
Data Loading...
